首页> 中文期刊> 《中国药业》 >医药流通领域商业贿赂的经济伦理思考

医药流通领域商业贿赂的经济伦理思考

         

摘要

医药流通领域商业贿赂行为是企业漠视商业伦理和社会责任缺失的表现,反映出当前市场经济秩序存在深层次问题,亟待通过改革加以调整。该文从经济伦理角度分析了医药流通领域商业贿赂行为的成因,认为企业内部疏于管控、管理层社会责任意识淡薄是导致商业贿赂的直接原因,“以药养医”卫生体制是造成医药流通领域商业贿赂盛行的根源。建立和维护公正的市场经济秩序需要各方共同努力,企业要强化商业伦理和社会责任意识,规范经营行为;监管部门要依法强化监管,严惩违规行为;行业协会要建立行业伦理和社会责任标准,引导企业自律。%The commercial bribery behavior in the pharmaceutical circulation field is the manifestation of enterprises for neglecting the business ethics and social responsibility and reflects the deep-seated problems existing in the current market economy order,which ur-gently demands to be rectified through reform. This paper analyzes the causes of commercial bribery from the perspective of business ethics. It is considered that neglecting the internal control and the weak awareness of corporation social responsibility(CSR)are the di-rect causes leading to the commercial bribery,and the health system of drug-maintaining-medicine is the root source giving rise to the commercial bribery prevailing. The establishment and maintenance of fair market economy order require the joint efforts of relevant parties,enterprises should strengthen the awareness of business ethics and CSR and standardize the business behaviors;the supervision departments should severely punish the illegal behaviors;the industrial associations should establish the industrial ethical and social re-sponsibility standards,and guide the enterprise self-discipline.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号